![Paul Cox](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Cox
Investor Relations Kontakt bei
NEON THERAPEUTICS, INC.
Profil
Mr. Paul Cox is a Head-Investor Relations & Communications at BioNTech US, Inc. Mr. Cox was previously employed as a VP-Investor Relations & Corporate Communications by Dynavax Technologies Corp., a Vice President-Investor Relations by Voyager Therapeutics, Inc., a Senior Associate by Stern Investor Relations, Inc., a Vice President-Investor Relations & Communications by Kymera Therapeutics, Inc., a President & Director-Boston Chapter by National Investor Relations Institute, and a Head-Investor Relations by SAGE Therapeutics, Inc. He received his undergraduate degree from the University of Massachusetts and a graduate degree from Harvard Extension School.
Aktive Positionen von Paul Cox
| Unternehmen | Position | Beginn |
|---|---|---|
| NEON THERAPEUTICS, INC. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Paul Cox
| Unternehmen | Position | Ende |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Investor Relations Kontakt | 01.04.2026 |
| VOYAGER THERAPEUTICS, INC. | Investor Relations Kontakt | 01.11.2020 |
| SAGE THERAPEUTICS, INC. | Investor Relations Kontakt | 01.03.2019 |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Corporate Officer/Principal | 31.12.2015 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
Ausbildung von Paul Cox
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
34
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Finance |
Harvard Extension School
 Harvard Extension School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
